The effect of glucagon-like peptide 1 on cardiovascular risk

被引：0
|
作者：
Jacob Sivertsen
Jaya Rosenmeier
Jens J. Holst
Tina Vilsbøll
机构：
[1] Gentofte Hospital,Department of Cardiology
[2] University of Copenhagen,Diabetes Research Division, Department of Internal Medicine
[3] Gentofte Hospital,Department of Biomedical Sciences
[4] University of Copenhagen,undefined
[5] The NovoNordisk Foundation Center for Basic Metabolic Research,undefined
[6] The Panum Institute,undefined
[7] University of Copenhagen,undefined
来源：
Nature Reviews Cardiology | 2012年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Glucagon-like peptide 1 (GLP)-based therapies reduce blood glucose levels in patients with type 2 diabetes mellitus. Interestingly, GLP 1 receptor agonists can also have beneficial effects on cardiovascular risk. Dr. Sivertsen and colleagues provide an overview of the cardiovascular mechanisms targeted by GLP 1-based therapies and discuss clinical data for long-term management of cardiovascular risk in patients treated with these agents.
引用
收藏
页码：209 / 222
页数：13
相关论文
共 50 条
  • [41] Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
    Francisco Kerr Saraiva
    Andrei C Sposito
    Cardiovascular Diabetology, 13
  • [42] Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
    Yixing Li
    Paul D. Rosenblit
    Current Cardiology Reports, 2018, 20
  • [43] Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: Is It a Class Effect?
    Li, Yixing
    Rosenblit, Paul D.
    CURRENT CARDIOLOGY REPORTS, 2018, 20 (11)
  • [44] Aspiration risk with glucagon-like peptide 1 (GLP-1) agonists
    Marroquin-Harris, M.
    Olesnicky, B.
    ANAESTHESIA, 2023, 78 (12) : 1524 - 1524
  • [45] Glucagon-like peptide 1 in health and disease
    Andersen, Andreas
    Lund, Asger
    Knop, Filip K.
    Vilsboll, Tina
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 14 (07) : 390 - 403
  • [46] Glucagon-like peptide-1 and satiety
    S. R. Bloom
    Nature, 1997, 385 : 214 - 214
  • [47] Is glucagon-like peptide 1 an incretin hormone?
    Nauck, MA
    DIABETOLOGIA, 1999, 42 (03) : 373 - 379
  • [48] Glucagon-Like Peptide-1 and Diabetes
    Monami, Matteo
    EXPERIMENTAL DIABETES RESEARCH, 2011,
  • [49] Is Glucagon-like peptide-1 for real?
    Murr, Michel M.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2014, 10 (05) : 786 - 786
  • [50] Is glucagon-like peptide 1 an incretin hormone?
    Michael A. Nauck
    Diabetologia, 1999, 42 : 373 - 379
12345